Filing Details

Accession Number:
0001062993-22-024057
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-19 12:30:11
Reporting Period:
2022-12-15
Accepted Time:
2022-12-19 12:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
49071 Humana Inc HUM Hospital & Medical Service Plans (6324) 610647538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565717 S. Timothy Huval Humana Inc.
500 West Main Street
Louisville KY 40202
Chief Administrative Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Humana Common Acquisiton 2022-12-15 404 $0.00 5,372 No 4 M Direct
Humana Common Disposition 2022-12-15 185 $510.02 5,187 No 4 F Direct
Humana Common Acquisiton 2022-12-15 405 $0.00 5,592 No 4 M Direct
Humana Common Disposition 2022-12-15 185 $510.02 5,407 No 4 F Direct
Humana Common Acquisiton 2022-12-15 361 $0.00 5,768 No 4 M Direct
Humana Common Disposition 2022-12-15 165 $510.02 5,603 No 4 F Direct
Humana Common Disposition 2022-12-16 635 $497.71 4,968 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Humana Common Restricted Stock Units Disposition 2022-12-15 404 $0.00 404 $0.00
Humana Common Restricted Stock Units Disposition 2022-12-15 405 $0.00 405 $0.00
Humana Common Restricted Stock Units Disposition 2022-12-15 361 $0.00 361 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
406 No 4 M Direct
724 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Humana Common Options $307.97 2026-02-25 324 324 Direct
Humana Common Options $350.79 2027-02-24 2,030 2,030 Direct
Humana Common Options $376.61 2028-02-22 3,336 3,336 Direct
Humana Common Options $425.06 2029-02-21 3,932 3,932 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-02-25 324 324 Direct
2027-02-24 2,030 2,030 Direct
2028-02-22 3,336 3,336 Direct
2029-02-21 3,932 3,932 Direct
Footnotes
  1. Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.
  2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
  3. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
  4. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
  5. Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
  6. Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
  7. Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
  8. Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
  9. Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return.
  10. Price reported is weighted average sales price.